Items where authors include "Chowdhury, S."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Akritidis, D., Bacer, S., Zanis, P. et al. (13 more authors) (2024) Strong increase in mortality attributable to ozone pollution under a climate change and demographic scenario. Environmental Research Letters, 19 (2). 024041. ISSN 1748-9326

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Dwivedi, Y.K., Kshetri, N., Hughes, L. et al. (70 more authors) (2023) “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy. International Journal of Information Management, 71. 102642. ISSN 0268-4012

Adisa, A., Bahrami-Hessari, M., Bhangu, A. orcid.org/0000-0001-5999-4618 et al. (2460 more authors) (2023) Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. British Journal of Surgery, 110 (7). pp. 804-817. ISSN 0007-1323

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Rahman, M.N., Chowdhury, S. and Mazgutova, D. (2023) Rethinking Teaching Listening Skills: A Case Study. Language Teaching Research Quarterly, 33. pp. 176-190.

Glasbey, J.C., Abbott, T.E.F., Ademuyiwa, A. et al. (4500 more authors) (2022) Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. The Lancet, 400 (10363). pp. 1607-1617. ISSN 0140-6736

Parker, C.C., James, N.D. orcid.org/0000-0002-7314-8204, Brawley, C.D. orcid.org/0000-0003-3641-278X et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Fulton, B., Jones, R., Powles, T. et al. (8 more authors) (2020) ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer. Trials, 21. 344. ISSN 1745-6215

Clarke, N.W., Ali, A., Ingleby, F.C. et al. (47 more authors) (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer : long-term survival results from the STAMPEDE trial. Annals of Oncology. 396. pp. 1-12. ISSN 0923-7534

Mehra, P., Sarkar, B. orcid.org/0000-0002-4196-1225, Bolan, N. et al. (2 more authors) (2019) Impact of carbonates on the mineralisation of surface soil organic carbon in response to shift in tillage practice. Geoderma, 339. pp. 94-105. ISSN 0016-7061

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Chowdhury, S. orcid.org/0000-0001-7585-7461 and Burton, C. orcid.org/0000-0003-0233-2431 (2017) Associations of treatment effects between follow-up times and between outcome domains in interventions for somatoform disorders: Review of three Cochrane reviews. Journal of Psychosomatic Research, 98. pp. 10-18. ISSN 0022-3999

Powles, T., Brown, J., Larkin, J. et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534

Preprint

Bhaumik, S., Chowdhury, S., Dimova, R. et al. (1 more author) (2023) Identity, communication, and conflict: an experiment. [Preprint] (Submitted)